# Johnson & Johnson (JNJ) — Q4-2021 Earnings Results

**Report date:** 2022-01-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2021

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.13 | N/A | +0.33% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook, emphasizing their commitment to growth despite current challenges. They noted the importance of maintaining strong operational performance.

**Key quotes:**

> Management expressed confidence in the company's long-term growth prospects.

> They highlighted ongoing investments in innovation and product development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson is performing well in terms of earnings per share, beating expectations slightly. However, the lack of revenue figures and guidance leaves some uncertainty for investors. The stock reaction is not available, which makes it difficult to gauge immediate market sentiment following the report.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2021_